$124 Million is the total value of Velan Capital Investment Management LP's 30 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 100.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
Exit | AIRSCULPT TECHNOLOGIES INCcall | $0 | – | -75,000 | -100.0% | -0.60% | – | |
AVDL | Exit | AVADEL PHARMACEUTICALS PLCsponsored adr | $0 | – | -100,000 | -100.0% | -1.53% | – |
IOVA | Exit | IOVANCE BIOTHERAPEUTICS INC | $0 | – | -240,000 | -100.0% | -1.57% | – |
ETNB | Exit | 89BIO INC | $0 | – | -95,000 | -100.0% | -1.67% | – |
CTLT | Exit | CATALENT INC | $0 | – | -50,000 | -100.0% | -2.01% | – |
PNT | Exit | POINT BIOPHARMA GLOBAL INC | $0 | – | -342,936 | -100.0% | -2.88% | – |
GRTX | Exit | GALERA THERAPEUTICS INC | $0 | – | -1,000,000 | -100.0% | -2.90% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-13
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
LANTHEUS HLDGS INC | 8 | Q3 2023 | 18.0% |
ADMA BIOLOGICS INC | 8 | Q3 2023 | 13.7% |
JASPER THERAPEUTICS INC | 8 | Q3 2023 | 17.8% |
TELA BIO INC | 8 | Q3 2023 | 7.6% |
REZOLUTE INC | 8 | Q3 2023 | 1.3% |
OPTINOSE INC | 7 | Q3 2023 | 7.9% |
IMMUNOCORE HLDGS PLC | 6 | Q1 2023 | 13.7% |
ALIMERA SCIENCES INC | 6 | Q3 2023 | 34.0% |
QUIPT HOME MEDICAL CORP | 6 | Q3 2023 | 4.8% |
SONIDA SENIOR LIVING INC | 6 | Q1 2023 | 2.5% |
View Velan Capital Investment Management LP's complete holdings history.
Latest filings
Type | Filed |
---|---|
SC 13G | 2024-03-28 |
13F-HR | 2024-02-14 |
4 | 2024-02-09 |
SC 13D/A | 2024-02-09 |
SC 13G/A | 2024-01-29 |
13F-HR | 2023-11-13 |
4 | 2023-10-04 |
4 | 2023-08-17 |
SC 13D/A | 2023-08-16 |
13F-HR | 2023-08-11 |
View Velan Capital Investment Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.